(Q43840478)
Statements
1 reference
Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer (English)
1 reference
Johanna C Bendell
1 reference
Thomas J Ervin
1 reference
David Gallinson
1 reference
Jaswinder Singh
1 reference
James A Wallace
1 reference
Mansoor N Saleh
1 reference
Marcy Vallone
1 reference
See-Chun Phan
1 reference
Stephen P Hack
1 reference
27 June 2013
1 reference
1 reference
12
1 reference
3
1 reference
218-222
1 reference
Identifiers
1 reference
1 reference